These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34514537)

  • 1. Age-Related Change in Hepatic Clearance Inferred from Multiple Population Pharmacokinetic Studies: Comparison with Renal Clearance and Their Associations with Organ Weight and Blood Flow.
    Soejima K; Sato H; Hisaka A
    Clin Pharmacokinet; 2022 Feb; 61(2):295-305. PubMed ID: 34514537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method.
    Calvier EAM; Krekels EHJ; Johnson TN; Rostami-Hodjegan A; Tibboel D; Knibbe CAJ
    AAPS J; 2019 Mar; 21(3):38. PubMed ID: 30850923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on the hepatic clearance of propranolol in rats.
    Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H
    J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio.
    Salem F; Abduljalil K; Kamiyama Y; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):1099-102. PubMed ID: 26864786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
    Kanamori M; Takahashi H; Echizen H
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):485-92. PubMed ID: 12698985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
    Yuan R; Venitz J
    Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children.
    Yokoi T
    J Toxicol Sci; 2009; 34 Suppl 2():SP307-12. PubMed ID: 19571484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron.
    Dickinson J; Lewand M; Sawamoto T; Krauwinkel W; Schaddelee M; Keirns J; Kerbusch V; Moy S; Meijer J; Kowalski D; Morton R; Lasseter K; Riff D; Kupčová V; van Gelderen M
    Clin Drug Investig; 2013 Jan; 33(1):11-23. PubMed ID: 23208320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of pharmacokinetic models of hepatic elimination.
    Morgan DJ; Smallwood RA
    Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical and physiological basis for the allometric scaling of cisplatin clearance in dogs.
    Achanta S; Sewell A; Ritchey JW; Broaddus K; Bourne DW; Clarke CR; Maxwell LK
    J Vet Pharmacol Ther; 2016 Jun; 39(3):224-36. PubMed ID: 26440900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of renal failure on hepatic drug clearance.
    Touchette MA; Slaughter RL
    DICP; 1991 Nov; 25(11):1214-24. PubMed ID: 1763539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in hepatic function. Implications for drug therapy.
    Woodhouse K; Wynne HA
    Drugs Aging; 1992; 2(3):243-55. PubMed ID: 1606355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in pharmacokinetics in elderly patients].
    Nadai M; Katoh M
    Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
    Björkman S
    Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic change in the liver following hepatic resection in the dog. A comparative study by the 198Au colloid method, KICG and the H2 clearance method].
    Tsumura M
    Nihon Geka Gakkai Zasshi; 1986 May; 87(5):536-46. PubMed ID: 3012315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.